Health AI Central
Share:
Peer-Reviewed Publication
J Manag Care Spec Pharm2021;27(6):724-731.June 1, 2021Journal Article

Impact of a diabetes remote monitoring program on medication adherence.

Kiraat D Munshi1, Kyle Amelung2, Callie S Carter3, Roberta James4, Bimal R Shah5, Rochelle R Henderson1
1Health Services Research, Express Scripts, Memphis, TN.
2Clinical Solutions, Express Scripts, Memphis, TN.
3Office of Clinical Evaluation & Policy, Express Scripts, Memphis, TN.
4Clinical Analytics, Livongo, Mountain View, CA.
5Chief Medical Officer, Livongo, Mountain View, CA, and Duke University School of Medicine, Durham, NC.
PubMed PMC DOI PDF

Abstract

BACKGROUND: Medication nonadherence in diabetes is well documented to be associated with inadequate glycemic control. Through remote blood glucose (BG) monitoring, unlimited test strip and lancet supplies, personal coaching, and online access to clinical information and educational resources, diabetes remote monitoring (DRM) programs may provide a solution. OBJECTIVE: To examine the relationship b…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.